ClinicalTrials.Veeva

Menu

The DistaSense VITALS Study

L

Life Detection Technologies

Status

Enrolling

Conditions

Detection of Heart Rate and Respiratory Rate

Treatments

Diagnostic Test: DistaSense and Polysomnography

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT07217327
TP-25-002

Details and patient eligibility

About

A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.

Enrollment

20 estimated patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age ≥ 22 years
  2. Fluent in English
  3. Willing and cognitively able to provide informed consent
  4. BMI < 36
  5. Expected by the investigator to achieve sufficient sleep duration for a minimum of 4 hours of meaningful data (e.g., absence of significant insomnia)
  6. Able to complete the scripted portion of the evaluation

Exclusion criteria

  1. Pregnant
  2. Sufficiently broken, damaged or irritated skin or rashes near the sensor application sites such that investigator believes should be precluded from enrollment
  3. Subjects with electronic implants of any kind (e.g. pacemaker)
  4. Subjects that are Life Detection Technology employees or shareholders, or family of a Life Detection Technology employee or shareholder

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems